Autoimmune Hair Loss
Nektar Therapeutics is involved in clinical research for alopecia areata, with a focus on severe to very severe disease and the restoration of scalp hair growth.
- Severe alopecia areata
- Hair loss reduction
- Immune-mediated follicle disease
This area reflects interest in therapies aimed at modifying the underlying immune dysregulation associated with patchy and extensive hair loss.
Inflammatory Skin Disease
The sponsor also supports research in atopic dermatitis, including adult patients with moderate-to-severe disease and persistent inflammatory skin symptoms.
- Moderate-to-severe atopic dermatitis
- Skin inflammation
- Eczema symptom control
Clinical activity in this field centers on improving disease burden in biologic-naive patients with active eczema.
Immune-Mediated Therapeutics
Across both programs, Nektar Therapeutics is engaged in research targeting immune-mediated disorders with relevance to dermatologic autoimmunity and chronic inflammation.
- Immune pathway modulation
- Dermatology-focused immunotherapy
- Chronic inflammatory conditions
The therapeutic emphasis spans conditions where altered immune signaling contributes to persistent skin and hair follicle disease.
